Canadian guideline for Parkinson disease

David Grimes; Megan Fitzpatrick; Joyce Gordon; Janis Miyasaki; Edward A Fon; Michael Schlossmacher; Oksana Suchowersky; Alexander Rajput; Anne Louise Lafontaine; Tiago Mestre; Silke Appel-Cresswell; Suneil K Kalia; Kerrie Schoffer; Mateusz Zurowski; Ronald B Postuma; Sean Udow; Susan Fox; Pauline Barbeau; Brian Hutton

doi:10.1503/cmaj.181504

Canadian guideline for Parkinson disease

CMAJ. 2019 Sep 9;191(36):E989-E1004. doi: 10.1503/cmaj.181504.

Authors

David Grimes¹, Megan Fitzpatrick², Joyce Gordon², Janis Miyasaki², Edward A Fon², Michael Schlossmacher², Oksana Suchowersky², Alexander Rajput², Anne Louise Lafontaine², Tiago Mestre², Silke Appel-Cresswell², Suneil K Kalia², Kerrie Schoffer², Mateusz Zurowski², Ronald B Postuma², Sean Udow², Susan Fox², Pauline Barbeau², Brian Hutton²

Affiliations

¹ The Ottawa Hospital, University of Ottawa Brain and Mind Research Institute (Grimes, Fitzpatrick, Schlossmacher, Mestre), Ottawa, Ont.; Parkinson Canada (Gordon), Toronto, Ont.; University of Alberta Hospital (Miyasaki), Edmonton, Alta.; Montreal Neurological Institute (Fon), McGill University, Montréal, Que.; University of Alberta (Suchowersky), Edmonton, Alta.; Royal University Hospital (Rajput), University of Saskatchewan, Saskatoon, Sask.; Montreal General Hospital (Lafontaine, Postuma), McGill University, Montréal, Que.; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health (Appel-Cresswell), University of British Columbia, Vancouver, BC; Toronto Western Hospital (Kalia, Zurowski, Fox), University of Toronto, Toronto, Ont.; Dalhousie University (Schoffer), Halifax, NS; University of Manitoba Rady Faculty of Health Sciences (Udow), Winnipeg, Man.; Knowledge Synthesis Group (Barbeau, Hutton), Ottawa Hospital Research Institute, Ottawa, Ont. dagrimes@toh.on.ca.
² The Ottawa Hospital, University of Ottawa Brain and Mind Research Institute (Grimes, Fitzpatrick, Schlossmacher, Mestre), Ottawa, Ont.; Parkinson Canada (Gordon), Toronto, Ont.; University of Alberta Hospital (Miyasaki), Edmonton, Alta.; Montreal Neurological Institute (Fon), McGill University, Montréal, Que.; University of Alberta (Suchowersky), Edmonton, Alta.; Royal University Hospital (Rajput), University of Saskatchewan, Saskatoon, Sask.; Montreal General Hospital (Lafontaine, Postuma), McGill University, Montréal, Que.; Pacific Parkinson's Research Centre, Djavad Mowafaghian Centre for Brain Health (Appel-Cresswell), University of British Columbia, Vancouver, BC; Toronto Western Hospital (Kalia, Zurowski, Fox), University of Toronto, Toronto, Ont.; Dalhousie University (Schoffer), Halifax, NS; University of Manitoba Rady Faculty of Health Sciences (Udow), Winnipeg, Man.; Knowledge Synthesis Group (Barbeau, Hutton), Ottawa Hospital Research Institute, Ottawa, Ont.

No abstract available

Publication types

Practice Guideline

MeSH terms

Canada
Decision Making, Shared
Deep Brain Stimulation / methods*
Disease Progression
Dopamine Agonists / therapeutic use*
Exercise Therapy / methods*
Humans
Palliative Care*
Parkinson Disease / diagnosis*
Parkinson Disease / physiopathology
Parkinson Disease / therapy
Patient Education as Topic
Policy Making
Quality of Life

Substances

Dopamine Agonists